Pulsenmore Ltd.
Close on Oct 19, 2026
About Pulsenmore
Surgical & Medical Instruments & Apparatus, SIC 3841
Pulsenmore Ltd. is a medical device company that develops, manufactures, and markets portable, non-invasive ultrasound solutions designed for home use. The company offers two main products, the Pulsenmore ES and Pulsenmore FC, while also developing the Pulsenmore MC and an assisted service for conducting biophysical profile tests in high-risk pregnancies. Its technology enables home-based ultrasound scans across obstetrics and gynecology, with applications extending to pulmonary medicine, cardiology, and urology. Pulsenmore provides its solutions primarily to healthcare organizations and patient end-users, including an ongoing commercial relationship with Clalit Health Services.
The company maintains its principal executive offices and operational headquarters in Omer, Israel. Pulsenmore focuses on commercializing its ultrasound devices across domestic and global markets, with business operations and revenue activities spanning Israel, the United States, Europe, and South Korea. Manufacturing and final device assembly are supported through third-party subcontractors.
Summary of the business section of Pulsenmore's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Pulsenmore Ltd.
- Founded
- 2014
- Headquarters
- Israel, Israel
- Address
- Omarim 8, Omer 8496500
- Phone
- 972 52 606 2075
- Employees
- 63, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Auditor
- Kesselman & Kesselman, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- PLSM
- Exchange
- Nasdaq
- Shares outstanding
- 7M, Mar 15, 2026
- Filer category
- Non-accelerated filer<br>Emerging growth company
- SEC CIK
- 2064764
- CUSIP
- M8S7C5117
- ISIN
- USM8S7C51179
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Elazar Sonnenschein | Chief Executive Officer, Director | 1,872,092 |
| Eran Hirsh | Chief Financial Officer | – |
| Michael Hamelsdorf | GC & Corporate Secretary | – |
| Minelu Sonnenschein | VP R&D | – |
| Meir Shmouely | VP Software Development | 13,812 |
| Jonathan Adereth | Director | 129,062 |
| Racheli Guz-Lavi | Director | – |
| Anat Loewenstein | Director | – |
| Hagai Itkin | Director | – |
| Linda Messalem | Director | – |